CONCLUSION
While rates of adverse neonatal outcomes were similar in index and
subsequent GDM pregnancies, the risk was greatly increased in women who
had an adverse outcome in the first pregnancy. This is despite decreased
rates of adverse delivery outcomes. Our study identifies a group of
women with recurrent GDM and previous LGA, who may stand to gain the
most from intensive management of their glucose levels and weight. It
also discerns a group of women with recurrent GDM and previous SGA in
whom intensive or early therapy might potentially be unwarranted, given
the high risk of recurrent SGA and the low risk of LGA.